Prediabetes model mice in which more than one gene associated with diabetes is knocked down simultaneously are potentially useful for pharmaceutical and medical studies of diabetes. However, the effective conditions for sufficient knockdown in vivo are dependent on the intrinsic properties of the target genes. It is necessary to investigate which genes are applicable or not to the in vivo knockdown method. In this study, insulin receptor substrate 1 and 2 (Irs-1, Irs-2) were selected as target genes. Effective siRNAs against the respective genes were designed, and their efficacy was confirmed by cell-based experiments. Based on the results of siRNAs, shRNA expression vectors against Irs-1 and Irs-2 were constructed, respectively. Their efficacy was also confirmed by cell-based experiments. A hydrodynamic method was applied to the delivery of the vectors to mice. This method was found to be effective for predominant delivery to the liver by demonstrative delivery of an EGFP expression vector and successive histochemical analysis. Fifty micrograms of the shRNA expression vector was injected into the tail vein. After 24 h, the liver, pancreas, and muscle were isolated, and the expression levels of Irs-1 and Irs-2 were analyzed by quantitative RT-PCR. In the liver, Irs-2 was effectively knocked down to 60% of the control level, but Irs-1 was not influenced even under the same conditions. The protocol developed here is feasible for the selection of genes fit for in vivo knockdown method.
Introduction
rnai has recently attracted much attention from the viewpoint of pharmaceutical and medical studies. in fact, effective RNAi's against some specific genes are already commercially available and referred to as rnai therapy [1, 13, 21] . an outstanding advantage of the rnai method is the ability to regulate simultaneously and quantitatively more than one gene both in vitro and in vivo. Such a method is believed to be useful for studies on adult diseases and lifestyle-related illness, because they are thought to be caused by multiple gene deficiencies and dysfunctions. However, there is no general protocol to prepare effective rnai reagents for any genes. The effective conditions for sufficient knockdown in vivo are understood to be dependent on the intrinsic properties of the target genes in vivo. therefore, we have to develop a useful protocol to investigate which genes are applicable or not to the in vivo knockdown method.
We are particularly interested in prediabetes. according to a governmental report, there are more than 20 million people with prediabetes in Japan. therefore, it is an urgent requirement to develop a prediabetes model that may facilitate studies focused on relevant issues. our strategy was to develop a library of mouse embryonic stem (ES) cell lines in which one or two genes are knocked down, to differentiate them into insulin generating cells for cell-based experiments, and to produce knockdown mice from the knockdown ES cells. in the first step, we selected 8 genes relevant to typical symptoms in diabetes such as deficiencies in insulin production, insulin reception, and glucose-stimulated insulin secretion. the genes were Pdx-1, Irs-1, Kir6.2, Irs-2, Gk, Shp, Hnf-1α, and Hnf-1β. a Pdx-1 and Irs-1 double knockdown cell line was successfully used in the quantitative analysis for a differentiated cell-based experiment [18] . Knockdown mouse production, however, has not been attained in spite of various attempts, and therefore, we intended to develop an alternative method.
this study focused on development of a prediabetes model specifically relevant to insulin resistance, because insulin resistance is the predominant symptom of type 2 diabetes that is most frequently occurs in Japanese. insulin resistance is understood to be caused by a deficiency of genes involved in insulin reception and its downstream signaling pathway. The deficiency of insulin receptor substrate 1 (Irs-1) and/or 2 (Irs-2) is often observed in patients, and its roles in insulin resistance are well speculated [7] . Irs-2 in liver modulates the phosphatidylinositol 3-kinase/akt/Foxo1 pathway that controls the suppression of gluconeogenic genes [22] . Phosphorylation of Irs-1 on a definite serine residue may moderate insulin resistance in vivo but enhance it in cell-based experiments [4] . the degradation of Irs-1 protein in hepatocytes is involved in high glucose-induced insulin resistance [12] . these indicate multifunctional roles of Irs-1 and Irs-2 in insulin resistance relevant reactions especially in the liver. therefore, we selected these 2 genes as the first target.
instead of the production of mouse clones, we intended to develop a methodology for simultaneous delivery of rnai's against Irs-1 and/or Irs-2. Delivery methods are divided into viral [19, 21] and non-viral [17] methods. the latter includes those using liposomes [3, 16, 21] , nanoparticles [23] , and a hydrodynamic method [2] . regarding rnai, a viral delivery method was applied to shrna expression vector [21] , and nanoparticles were used as a carrier of sirna in humans [5] . among these methods, we selected hydrodynamic gene delivery [2] , which was originally reported more than 10 years ago [14] . this method is technically simple and seems to be useful for delivery of a large amount of reagent at high speed specifically to the liver. The liver is a flexible organ and ready to swell in response to injection pressure. Consequently, the injected solution will be absorbed mainly in the liver.
in this study, we developed a protocol to prepare effective rnai reagents against target genes and to validate them. its feasibility will be demonstrated by successful preparation of effective rnai reagents against Irs-1 and/or Irs-2.
Materials and Methods

Cell culture
Mouse insulinoma line 6 (Min6) [15] cells were kindly donated by Dr. J. Miyazaki, osaka university, and grown in DMEM-high glucose (invitrogen, Carlsbad, Ca, uSa) supplemented with 13% fetal bovine serum (FBS) and 2-mercaptoethanol in a humidified atmosphere with 5% Co 2 at 37°C. siRNA sirna was synthesized by Japan bio Services Co., Ltd.(Saitama, Japan). after preliminary tests of candidate sequences, we selected the most active ones against Irs-1 and Irs-2, respectively. the sirna sequences used here are listed in a 5' to 3' orientation as follows.
Irs-1: sense, auCuagaagaaggCauggg tt; antisense, CCCaugCCuuCuuCuagautt Irs-2: sense, uuuaCugggaagguCCugCtt; antisense, gCaggaCCuuCCCaguaaatt.
siRNA transfection in a cell-based experiment Min6 cells were seeded at 2.5 × 10 5 cells per well in 6-well plates and cultured for 24 h before transfection. the medium volume was 2 ml per well. sirna duplexes against respective genes were transfected into the cells using Lipofectamine 2000 (LP2000) (invitrogen), a cationic lipid transfection reagent. Four hours after trans-fection, the medium containing LP2000 was replaced with fresh culture medium (same as indicated above).
Semi-quantitative RT-PCR
twenty-four hours after transfection, cells were retrieved using iSogEn (niPPon gEnE, tokyo, Japan), and total rna was extracted. reverse transcription was performed, and cDna was synthesized using oligo dt primers. relative mrna expression levels of respective genes were measured by reverse transcription PCr (rtPCr) with gotaq green Master Mix (Promega Corporation, Madison, Wi, uSa). the following primer sequences were used for PCr.
Irs-1:
reverse, 5'-tCCaCCaCCCtgttgCtgta-3' Amplification was performed under the following conditions using a geneamp PCr system 9700 (applied biosystems, Carlsbad, Ca, uSa).
Irs-1 and Irs-2: pre-denaturation at 95°C for 2 min, denaturation at 95°C for 30 s, annealing at 55°C for 30 s, extension at 72°C for 1 min, and final extension at 72°C for 5 min.
Gapdh: pre-denaturation at 95°C for 2 min, denaturation at 94°C for 30 s, annealing at 55°C for 30 s, extension at 72°C for 1 min, and final extension at 72°C for 7 min.
After amplification, 10 µl of the PCr products were subjected to electrophoresis on 3% agarose gel. the gel was stained with ethidium bromide, and the fluorescence intensity of the PCR products was quantified using ImageJ (http://imagej.nih.gov/ij/).
Construction of shRNA expression vectors
the sequences of shrnas against Irs-1 and Irs-2 were designed according to the sequences of active sirnas against Irs-1 and Irs-2, respectively, and synthesized by Japan bio Services Co., Ltd. then the shrnas were inserted into a pSilencer 3.1-H1 neo vector (ambion, austin, tX, uSa) and pSilencer 3.1-H1 hygro vector, respectively, to construct shrna expression vectors, which were designated as pshirs1 and pshirs2, respectively. negative control vector (pshnega) was constructed by introducing a sequence of shrna that was thought to be inactive to any mrna of the mouse. pshirs1, pshIrs2, and pshNega were purified using a QIAGEN Plasmid Midi Kit (QIAGEN) before use, and their knockdown effects against respective target genes were confirmed in vitro using Min6 cells.
Hydrodynamic delivery markers
In order to confirm delivery to the liver by the hydrodynamic method, a fluorescent siRNA and fluorescent protein generating vector were prepared. sirna against Irs-1 was modified with an Alexa Fluor 555 (Molecular Probes, invitrogen) to visualize the physical delivery by the hydrodynamic method. an EgFP expression vector (pEgFP-C1) (Clontech Laboratories, inc.) was used to visualize the delivery of a gene while maintaining gene expression activity.
Transfection of shRNA expression vectors in a cell-based experiment
shrna expression vector (pshirs1, pshirs2, or pshnega) was transfected to Min6 cells by lipofection. twenty-eight microliters of LP2000 containing 8 µg of one of the shrna expression vectors was added to a well containing 2.5 × 10 5 cells. after incubation at 37°C for 4 h, the cells were collected, and rna was extracted from the cells. the expression intensity of Irs-1 or Irs-2 was estimated versus that of Gapdh by semi-quantitative rt-PCr.
Mice and intravenous infection
Six-to eight-week-old C57bL/6n male mice (approximately 20 g body weight) were purchased from Saitama Experimental animals Supply Co., Ltd. (Saitama, Japan) and used for all experiments. Mice were infected by hydrodynamic injection of TransIT-QR Hydrodynamic Delivery Solution (trHD) (Mirus bio, Madison, Wi, uSa) containing shrna expression vector into a tail vein. Each injection volume of trHD was no more than 2 ml and contained 50 µg of pshirs1, pshirs2, or pshnega. injection was performed at a speed of 5-7 s using a 5 ml-syringe and a 27-g needle (terumo, tokyo, Japan). Care and use of the mice were in accordance with the requirements established under the guide for the Care and use of the Laboratory animals by tokyo university of agriculture and technology, Japan.
Histochemical analysis
the distribution of hydrodynamic delivery markers in livers was investigated by histochemical analysis. Livers were collected from mice at 1 h after injection of alexa Fluor 555-labeled sirna (alexa-sirna) or at 24 h after injection of pEGFP-C1 and fixed in 4% paraformaldehyde for 24 h. then, they were dehydrated in 10% sucrose for 2 h, 20% sucrose for 2 h, and 30% sucrose for 24 h. Finally, they were frozen in 2-methyl butanol cooled with liquid nitrogen and stored at −80°C. Tenmicrometer-thick sections of frozen liver were prepared using a cryostat (HM550, Thermo Scientific, Waltham, Ma, uSa) and observed with a confocal laser scanning microscope (LSM 510, Carl Zeiss, oberkochen, germany). Each sample was stained with 4',6-diamidino-2-phenylindole (DAPI) in order to confirm the location of the nucleus.
Analysis of gene expression in the liver
Livers were collected from mice in the same way as above. total rna was extracted with iSogEn ii (niPPon gEnE) according to the manufacturer's instructions. the expression intensities of Irs-1, Irs-2, and other relevant genes were analyzed by real-time PCr (StepOnePlus, Applied Biosystems) and quantified as the relative values versus that of Gapdh.
Estimation of the amount of mRNA generated from shRNA expression vector in vivo
Even if shrna expression vector is physically introduced into cells in vivo, it is necessary to estimate the amount of mrna actually generated from the shrna expression vectors. Since mrna from shrna might be too short to be analyzed by PCr, we used an mrna for ampicillin-resistant protein that was constructed in the shrna expression vector. the number of mrna from shrna vectors is thought to be the same as that of the ampicillin-resistant protein. thus, the quantity of mrna for the ampicillin-resistant protein was determined by PCr versus that for Gapdh. besides the liver, we investigated the pancreas and muscle. the muscle was sampled from the thigh of a lower limb.
Results
Efficacy of siRNA's against Irs-1 and Irs-2 in MIN6 cells
The efficacy of siRNAs (siIrs1 and siIrs2) was tested by a cell-based experiment using Min6 cells. the concentration of sirna was varied from 1 nM to 100 nM. siIrs1 showed a sufficiently high knockdown effect, and the Irs-1 expression intensity became 10% versus the control at 100 nM (Fig. 1a) . siirs2 also showed high activity, and the Irs-2 expression intensity became 20% versus the control at 100 nM (Fig. 1b) . Since these siRNA's were sufficiently active, shRNA's against Irs-1 and Irs-2 were designed based on these sequences and then inserted into pSilencer vectors to construct pshirs1 and pshirs2, respectively.
Efficacy of pshIrs1 and pshIrs2 in MIN6 cells
the expression levels of Irs-1 and Irs-2 were 30 and 40%, respectively, versus the control (Fig. 2 ). the expression level of Irs-1 was lower than that of Irs-2. this indicates that the knockdown efficacy of pshIrs1 was stronger than that of pshirs2. this result did not contradict the results in Fig. 1 , in which the expression level of Irs-1 was slightly lower than that of Irs-2 under the knockdown conditions. one possible reason was that the intrinsic expression level of Irs-1 was lower than that of Irs-2. in fact, they were 1.26 and 1.69 versus that of Gapdh, respectively.
Optimum conditions of the hydrodynamic delivery method
When alexa-sirna was delivered, a large number of fluorescent spots of Alexa-siRNA were observed in a liver sample (Fig. 3a) . Each of the alexa-sirna spots overlapped with a DaPi-stained spot with a similar size. this indicates that the alexa-sirna was localized in the cell and especially condensed in or near the nucleus. analyzing these photographs, we estimated the transfection efficiency of Alexa-siRNA as ca. 20% in liver tissue. therefore, the present conditions of the hydrodynamic method were effective for physical delivery of reagents into liver cells.
When pEGFP-C1 was delivered, fluorescent spots of EgFP were observed in a liver sample (Fig. 3b) , though the number of spots was smaller than that of alexa-sirna spots. Every spot of EGFP fluorescence overlapped with a DaPi-stained spot with a smaller size. this indicates that EgFP distributed in the cytosol as well as in the nucleus. From the merged image, the transfection efficiency was estimated to be 7% in liver tissue. therefore, the present conditions were effective also for delivery of genes while maintaining their expression activity.
In vivo efficacy of pshIrs1 and pshIrs2
pshirs1, pshirs2, or pshnega was introduced into mice by the hydrodynamic delivery method, and its efficacy was assessed in the liver at 24 h after vector introduction.
It should be noted that it is difficult to deliver vectors into all cells evenly by the hydrodynamic method. therefore, the observed efficacy described below is thought to be the average of those of all cells composing the organ. as depicted in Fig. 4a, pshirs1 was not effective for Irs-1. in contrast, pshirs2 was effective enough to knock down the Irs-2 expression level to 60% versus the control (Fig. 4b) .
the expressions of Irs-1 and Irs-2 in other tissues were investigated for comparison. in the pancreas, shirs1 did not knock down Irs-1 but rather intensified it. On the other hand, shirs1 in muscle could knockdown Irs-1. in contrast, shirs2 could not knock down Irs-2 in the pancreas or muscle. Therefore, the efficacies of shIrs1 and shirs2 were tissue dependent.
In Fig. 4 , the efficacy of the knockdown effect is expressed by the relative value versus that of the control. Each of these control values was originally determined as the relative values versus that of Gapdh in the respective tissues. assuming that the expression intensity of Gapdh was the same in every tissue, the expression intensities of the controls for Irs-1 and Irs-2 at 3 tissues intensities (Fig. 4a, 4b, 4C, 4D , 4E, and 4F) were 0.6-1.0, 1.2-1.4, 0.05-0.07, 0.1-0.2, 3-9, and 3-4, respectively. it is worth noting that the knockdown effect of shirs1 could be observed in tissue in which the Irs-1 expression level was high (muscle), while it could not be observed in tissue in which the Irs-1 expression level was low (liver). in contrast, gene activation could occur in tissue in which the Irs-1 expression level was much lower (pancreas).
Amount of mRNA from shRNA expression vector in vivo the tissue samples of liver, pancreas, and muscle were analyzed for the mrna of ampicillin-resistant protein. When shirs1, shirs2, and pshnega were delivered into the liver, for example, the amounts of mrna of ampicillin-resistant protein were 0.52, 0.54, and 0.43, respectively (n=3), versus that of Gapdh. there seemed to be no significant differences between the respective cases, and therefore, we grouped the 3 cases together, giving us an average of 0.5 (n=9). in the same way, we obtained averages of 0.05 and 0.03 for the pancreas and muscle, respectively, versus that for Gapdh (Fig. 5) .
in comparison with the liver, the number of shrnas in muscle was very low (1/100), and the control levels of Irs-1 and Irs-2 expressions were higher. Even under these conditions, however, the knockdown effect of Irs-1 was observed in muscle and not in liver. therefore, the specific efficacy of shRNA per molecule might be a tissue-dependent property, which needs to be further investigated from the practical viewpoint.
Discussion
in comparison with shrna expression vector, the direct introduction of sirna might be preferable for the quantitative knockdown of target genes. in the case of shRNA expression vector, the efficiencies of transcription and the posttranscriptional process should be considered when discussing the quantitative relationship between the quantity of delivered vectors and the intensity of knockdown effect. Practically, however, the cost of sirna is a critical problem. Moreover, sirna should be protected from attack by various blood components [6] . therefore, we preferred shrna expression vector to sirna.
regarding the delivery method, viral methods are thought to be more efficient than non-viral methods. However, the protocol for the preparation of a virus vector is more complicated than simple mixing with nonviral materials. therefore, we selected the hydrodynamic method as the appropriate non-viral method to use. in this method, a large quantity of solution is injected into a vein. the large capacity of the liver to swell permits this method. the concentration of vector in the delivered solution may be maintained at no lower than a tenfold dilution in the vein. However, it is difficult to deliver vectors into all cells evenly by the hydrodynamic method. this problem may be overcome by a catheter-based injection method [20] . under the present conditions, the shrna concentration in the injector was 25 µg/ml. assuming the dilution condition as described above, the vector concentration in the vein was estimated to be no lower than 2.5 µg/ml. this condition was comparable to the concentration in the cell-based experiment using Min6 (4 µg/ml).
as described above in the paragraph about the cellbased experiments, the knockdown level of a target gene might be dependent on its intrinsic expression level. if the number of mrnas for the target gene is much larger than the number of sirna molecules generated by the shRNA expression vector, the knockdown efficacy might not be observed. Irs-1 is the principal mediator of hepatic insulin action that maintains glucose homeostasis [8] . it was also reported that a dynamic functional relay between Irs-1 and Irs-2 was observed in hepatic insulin signaling during fasting and feeding [10] . these indicate that the expression level of Irs-1 changes sensitively in response to the variation in glucose condition. in fact, the Irs-1 expression level versus that of Gapdh increased sharply from 1.0 to 7.7 within 3 h after a glucose tolerance test, in which the oral dosage of glucose was 2 g per kg mouse weight (unpublished data). the expression level of Irs-2 is also dependent on the glucose condition, though it is less sensitive than Irs-1. Irs-1 and Irs-2 are relevant to insulin resistance in vivo, and their expression levels and the distribution of their product proteins, irs-1 and irs-2, are thought to be different [9, 11] . these should be some of the reasons for the different effectiveness of shrnas.
in order to avoid uncertainty regarding the intrinsic expression levels of both genes, we applied a fasting condition to test mice, because an extreme condition such as no glucose should suppress their levels down to their respective definite steady levels. Consequently, they could be maintained at the same level (1.00 ± 0.04, mean ± SEM; n=3), versus the Gapdh expression level in the liver (data of controls in Fig. 4a and 4b) . Even under this equivalent condition, however, only Irs-2 was effectively knocked down. therefore, we suspect that whether the shrna is effective or not depends upon the intrinsic properties of the gene in vivo.
In the specific case of Irs-1, the following speculation might be proposed. under normal metabolic conditions, Irs-1 is sensitive to a change in glucose condition as remarked above. under such an extreme condition as fasting, however, Irs-1 expression might drop to the lowest stable level and become insensitive to any extra modulation signals. this is probably another reason why shrna against Irs-1 was not apparently effective. However, these do not explain why only shrna against Irs-2 was effective in vivo. one of our ideas to overcome this problem is to improve the shrna expression vector to increase the copy number of shrna.
in conclusion, the protocol developed here was successfully applied to the selection of at least one gene, Irs-2, that was fit for the in vivo knockdown method. this indicates the feasibility of its application to other diabetes-related genes. therefore, the present study is an important step towards the future development of a library of shrna expression vectors for prediabetes models.
